Status:
RECRUITING
Fabry Cardiomyopathy: Identification of Early Myocardial Structural and Tissue Abnormalities Using Multiparametric MRI
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Vancouver General Hospital
The Cleveland Clinic
Conditions:
Fabry Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will evaluate whether cardiac MRI T1 and T2 mapping improves our ability to detect early abnormalities in the heart in patients with Fabry disease and identify patients at increase risk of ...
Detailed Description
Fabry disease is an inherited disorder that affects many organs in the body, including the heart. Men and women are both affected, with average life expectancy reduced by 10-20 years. The heart muscle...
Eligibility Criteria
Inclusion
- Fabry disease;
- Age ≥ 18 years.
Exclusion
- History of myocardial infarction;
- Contraindication to MRI.
Key Trial Info
Start Date :
June 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04856059
Start Date
June 15 2021
End Date
December 31 2026
Last Update
July 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network
Toronto, Ontario, Canada, M5G 2C4